Your browser doesn't support javascript.
loading
[Prognosis and survival of esophageal cancer in Cameroon: a prognostic study]. / Facteurs pronostiques du cancer de l'œsophage au Cameroun: étude multicentrique.
Nga, Winnie Tatiana Bekolo; Eloumou, Servais Albert Fiacre Bagnaka; Engbang, Jean Paul Ndamba; Bell, Esther Mbassi Dina; Mayeh, Anne Marthe Maison; Atenguena, Etienne; Biwole, Martin Essomba; Ayissi, Georges Barthélémy Nko'o; Kenfack, Gabin; Noah, Dominique Noah; Luma, Henry Namme; Sone, Albert Mouelle; Ndom, Paul; Ndam, Elie Claude Ndjitoyap.
Afiliação
  • Nga WTB; Service de Médecine Interne de l'Hôpital Général de Douala, Douala, Cameroun.
  • Eloumou SAFB; Faculté de Médecine et de Sciences Pharmaceutiques de Douala, Douala, Cameroun.
  • Engbang JPN; Service de Médecine Interne de l'Hôpital Général de Douala, Douala, Cameroun.
  • Bell EMD; Faculté de Médecine et de Sciences Pharmaceutiques de Douala, Douala, Cameroun.
  • Mayeh AMM; Faculté de Médecine et de Sciences Pharmaceutiques de Douala, Douala, Cameroun.
  • Atenguena E; Faculté de Médecine et de Sciences Pharmaceutiques de Douala, Douala, Cameroun.
  • Biwole ME; Service d'Oncologie et de Radiothérapie de l'Hôpital Général de Douala, Douala, Cameroun.
  • Ayissi GBN; Service d'Oncologie et de Radiothérapie de l'Hôpital Général de Douala, Douala, Cameroun.
  • Kenfack G; Service de Médecine et d'Oncologie de l'Hôpital Général de Yaoundé, Yaoundé, Cameroun.
  • Noah DN; Service d'Oncologie et de Radiothérapie de l'Hôpital Général de Douala, Douala, Cameroun.
  • Luma HN; Direction de la Lutte contre la Maladie- Ministère de la Santé Publique, Yaoundé, Cameroun.
  • Sone AM; Faculté de Médecine et de Sciences Biomédicales de Yaoundé, Yaoundé, Cameroun.
  • Ndom P; Faculté de Médecine et de Sciences Pharmaceutiques de Douala, Douala, Cameroun.
  • Ndam ECN; Service de Médecine Interne de l'Hôpital Général de Douala, Douala, Cameroun.
Pan Afr Med J ; 33: 73, 2019.
Article em Fr | MEDLINE | ID: mdl-31448035
ABSTRACT

INTRODUCTION:

Esophageal cancer is rare. Poor prognosis is due to delayed diagnosis. Five year survival is less than 20%. This study aimed to investigate the factors associated with survival of patients with esophageal cancer in Cameroon.

METHODS:

We conducted a prognostic study in the General Hospitals in Yaoundé and in Douala over a period of 11 years from 1 January 2005 to 31 December 2015. The parameters studied were those associated with survival. Survival was established on the basis of the date of diagnosis and of the date of death or of the last visit. SPSS software (Statistical Package for Social Sciences) version 23 allowed for data analysis. Kaplan Meier curve was used to estimate the survival function. Log RankTest allowed for comparison among the different groups. Cox regression helped to highlight the different factors associated with it. Significance level was set at 0.05.

RESULTS:

We collected data from 49 medical records. The average age of patients was 57.83 years. There was a male predominance (71.4%; n=35) with a sex ratio of 2.49. The follow-up period was 3.2 months. Median survival was 6.67 months (CI 95% [1.33-10.4]) and the average survival time was 7.99 months (CI 95% [4.42-11.17]). Multivariate-adjusted analysis showed that stage IV was a predictive factor of mortality (HR = 2.79; CI95% [1.13-6.89], p = 0.025]).

CONCLUSION:

Esophageal cancer is a rare disease with poor prognosis. Prognostic factor is the tumor stage.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas Idioma: Fr Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas Idioma: Fr Ano de publicação: 2019 Tipo de documento: Article